Parkinson's Disease Tulip


advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 04-16-2017, 07:05 AM #1
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
Default Article on media hype, from both a patient and a scientific perspective

I came across this recent article while I was chasing up some citations (related to another thread). As you can imagine, nilotinib gets a mention.

“Media Hype: Patient and Scientific Perspectives on Misleading Medical News” | Israel Robledo

There are also a couple of related articles from Scientific American and MJFF.

Social-Media Hype about Diseases and Treatments Does Patients No Favors - Scientific American Blog Network

A Patient's Perspective on the Risks of Misleading Medical News | Parkinson's Disease
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
johnt (04-16-2017)
 

Tags
article, imagine, mention, related, scientific


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
for alz, magnetic stimulation to the brain, restore a patient’s cognition - hype? soccertese Parkinson's Disease 0 08-26-2013 10:08 AM


All times are GMT -5. The time now is 10:55 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.